Publications by authors named "Daniel G Haller"

Claim this Profile
C
Characteristics of Patients and Prognostic Factors Across Treatment Lines in Metastatic Colorectal Cancer: An Analysis From the Aide et Recherche en Cancérologie Digestive Database.
Jean-Baptiste Bachet, Aimery de Gramont, Morteza Raeisi, Manel Rakez, Richard M Goldberg, Daniel G Haller

J Clin Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Impact of Early Treatment and Oxaliplatin Discontinuation in Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 11 Adjuvant Trials.
Claire Gallois, Qian Shi, Jeffrey P Meyers, Timothy Iveson, Steven R Alberts, Daniel G Haller

J Clin Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenetic study in gastric cancer patients treated with adjuvant fluorouracil/leucovorin or epirubicin/cisplatin/fluorouracil before and after chemoradiation on CALGB 80101 (Alliance).
Jai N Patel, Chen Jiang, Kouros Owzar, Flora Mulkey, Jasmine A Luzum, Daniel G Haller

Pharmacogenet Genomics· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary Chemoradiotherapy for Older Patients With Esophageal Cancer.
Jennifer R Eads, Daniel G Haller

JAMA Oncol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefit of Oxaliplatin in Stage III Colon Cancer According to IDEA Risk Groups: Findings from the ACCENT Database of 4934 Patients.
Ofer Margalit, Ben Boursi, Manel Rakez, André Thierry, Greg Yothers, Daniel G Haller

Clin Colorectal Cancer· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex and Adverse Events of Adjuvant Chemotherapy in Colon Cancer: An Analysis of 34 640 Patients in the ACCENT Database.
Anna D Wagner, Axel Grothey, Thierry Andre, Jesse G Dixon, Norman Wolmark, Daniel G Haller

J Natl Cancer Inst· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intergroup Randomized Phase III Study of Postoperative Oxaliplatin, 5-Fluorouracil, and Leucovorin Versus Oxaliplatin, 5-Fluorouracil, Leucovorin, and Bevacizumab for Patients with Stage II or III Rectal Cancer Receiving Preoperative Chemoradiation: A Trial of the ECOG-ACRIN Research Group (E5204).
A Bapsi Chakravarthy, Fengmin Zhao, Neal J Meropol, Patrick J Flynn, Lynne I Wagner, Daniel G Haller

Oncologist· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update on optimal treatment for metastatic colorectal cancer from the AGITG expert meeting: ESMO congress 2019.
David K Lau, Matthew Burge, Amitesh Roy, Ian Chau, Daniel G Haller

Expert Rev Anticancer Ther· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II Study of Celecoxib With Irinotecan, 5-Fluorouracil, and Leucovorin in Patients With Previously Untreated Advanced or Metastatic Colorectal Cancer.
Emerson Y Chen, Charles D Blanke, Daniel G Haller, Al B Benson, Tomislav Dragovich

Am J Clin Oncol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted therapy for metastatic colorectal cancer.
Timothy J Price, Monica Tang, Peter Gibbs, Daniel G Haller, Marc Peeters

Expert Rev Anticancer Ther· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant therapy for resected colon cancer 2017, including the IDEA analysis.
Monica Tang, Timothy Jay Price, Jeremy Shapiro, Peter Gibbs, Daniel G Haller

Expert Rev Anticancer Ther· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant Chemoradiotherapy With Epirubicin, Cisplatin, and Fluorouracil Compared With Adjuvant Chemoradiotherapy With Fluorouracil and Leucovorin After Curative Resection of Gastric Cancer: Results From CALGB 80101 (Alliance).
Charles S Fuchs, Donna Niedzwiecki, Harvey J Mamon, Joel E Tepper, Xing Ye, Daniel G Haller

J Clin Oncol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validity of Adjuvant! Online in older patients with stage III colon cancer based on 2967 patients from the ACCENT database.
Demetris Papamichael, Lindsay A Renfro, Christiana Matthaiou, Greg Yothers, Leonard Saltz, Daniel G Haller

J Geriatr Oncol· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment sequence of synchronously (liver) metastasized colon cancer.
Thomas Gruenberger, Geerard Beets, Jean-Luc Van Laethem, Philippe Rougier, Andrés Cervantes, Daniel G Haller

Dig Liver Dis· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update on optimal treatment for metastatic colorectal cancer from the ACTG/AGITG expert meeting: ECCO 2015.
Timothy J Price, Subotheni Thavaneswaran, Matthew Burge, Eva Segelov, Daniel G Haller

Expert Rev Anticancer Ther· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determinants of Early Mortality Among 37,568 Patients With Colon Cancer Who Participated in 25 Clinical Trials From the Adjuvant Colon Cancer Endpoints Database.
Winson Y Cheung, Lindsay A Renfro, David Kerr, Aimery de Gramont, Leonard B Saltz, Daniel G Haller

J Clin Oncol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Patient Factors on Recurrence Risk and Time Dependency of Oxaliplatin Benefit in Patients With Colon Cancer: Analysis From Modern-Era Adjuvant Studies in the Adjuvant Colon Cancer End Points (ACCENT) Database.
Manish A Shah, Lindsay A Renfro, Carmen J Allegra, Thierry André, Aimery de Gramont, Daniel G Haller

J Clin Oncol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer: Final Results of the NO16968 Randomized Controlled Phase III Trial.
Hans-Joachim Schmoll, Josep Tabernero, Jean Maroun, Filippo de Braud, Timothy Price, Daniel G Haller

J Clin Oncol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current opinion on optimal systemic treatment for metastatic colorectal cancer: outcome of the ACTG/AGITG expert meeting ECCO 2013.
Timothy J Price, Eva Segelov, Matthew Burge, Daniel G Haller, Niall C Tebbutt

Expert Rev Anticancer Ther· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of outcomes after fluorouracil-based adjuvant therapy for stages II and III colon cancer between 1978 to 1995 and 1996 to 2007: evidence of stage migration from the ACCENT database.
Qian Shi, Thierry Andre, Axel Grothey, Greg Yothers, Stanley R Hamilton, Daniel G Haller

J Clin Oncol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of age on the efficacy of newer adjuvant therapies in patients with stage II/III colon cancer: findings from the ACCENT database.
Nadine J McCleary, Jeffrey A Meyerhardt, Erin Green, Greg Yothers, Aimery de Gramont, Daniel G Haller

J Clin Oncol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Causes and management of early colorectal cancer.
Daniel G Haller

Chin Clin Oncol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant therapy of stage III colon cancer.
Weijing Sun, Daniel G Haller

Chin Clin Oncol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current opinion on optimal treatment for colorectal cancer.
Timothy J Price, Eva Segelov, Matthew Burge, Daniel G Haller, Stephen P Ackland

Expert Rev Anticancer Ther· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A call for opinions.
Daniel G Haller

Gastrointest Cancer Res· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis